Multi-Targeting Anticancer Activity of a New 4-Thiazolidinone Derivative with Anti-HER2 Antibodies in Human AGS Gastric Cancer Cells

Combining chemotherapy with immunotherapy still remains a regimen in anticancer therapy. Novel 4-thiazolidinone-bearing hybrid molecules possess well-documented anticancer activity, and together with anti-HER2 antibodies, may represent a promising strategy in treating patients with gastric cancer wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gornowicz, Agnieszka, Lesyk, Roman, Czarnomysy, Robert, Holota, Serhii, Shepeta, Yulia, Popławska, Bożena, Podolak, Magdalena, Szymanowski, Wojciech, Bielawski, Krzysztof, Bielawska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095353/
https://www.ncbi.nlm.nih.gov/pubmed/37047765
http://dx.doi.org/10.3390/ijms24076791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095353/
https://www.ncbi.nlm.nih.gov/pubmed/37047765
http://dx.doi.org/10.3390/ijms24076791

Ejemplares similares